D75.0
Familial erythrocytosis
Clinical Classification Guidelines
Inclusion Terms
- Benign polycythemia
- Familial polycythemia
Excludes Type 1
- hereditary ovalocytosis (D58.1)
Medical Intelligence & Overview
Familial erythrocytosis, also known as familial polycythemia, is a rare inherited condition characterized by an abnormal increase in red blood cells. Unlike other forms of polycythemia which can result from acquired conditions, this form is passed down through families and is generally considered benign. It leads to thicker blood which can increase the risk of blood clots and other complications, although many individuals experience few or no symptoms. Recognizing this condition is important for proper monitoring and management to prevent potential health issues related to increased blood viscosity.
Causes & Symptoms
Clinical Causes: Genetic mutations inherited from family members Alterations in genes that regulate red blood cell production Familial inheritance patterns, often following autosomal dominant transmission
Key Symptoms: Usually asymptomatic, but some may experience: Headaches Dizziness or lightheadedness Fatigue Flushed skin Itching, especially after a hot shower Frequent or unexplained blood clots in veins or arteries Visual disturbances in some cases
Diagnostic & Treatment
Diagnosis Path: Complete blood count (CBC): Elevated hematocrit and hemoglobin levels Family history assessment to identify inherited patterns Bone marrow examination to rule out other causes of increased red blood cell production Genetic testing to identify mutations associated with familial erythrocytosis Exclusion of secondary causes such as lung disease, tumors, or kidney conditions
Treatment Protocols: Regular blood tests to monitor red blood cell levels Phlebotomy (periodic blood removal) to reduce hematocrit levels in some cases Lifestyle modifications, such as staying hydrated and avoiding dehydration Managing any associated risk factors for blood clots Careful observation and follow-up with healthcare providers
Clinical Advice & FAQs
Billing Guidance
Is D75.0 a billable ICD-10 code?
Yes, D75.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D75.0?
Clinical documentation must specify the nature of Familial erythrocytosis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference